NCT05718843View on ClinicalTrials.gov

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

October 24, 2023

Study Completion Date

October 24, 2023

Conditions
Renal Insufficiency
Interventions
DRUG

BI 425809

BI 425809

Trial Locations (1)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05718843 - A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems | Biotech Hunter | Biotech Hunter